Detalles de la búsqueda
1.
Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease.
Clin Infect Dis
; 54(3): 408-13, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22095570
2.
The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements.
ESMO Open
; 6(2): 100087, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735800
3.
Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition.
J Intern Med
; 268(6): 530-9, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21073558
4.
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir.
Clin Pharmacol Ther
; 81(5): 708-12, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17329995
5.
Modeling and simulation to optimize the design and analysis of confirmatory trials, characterize risk-benefit, and support label claims.
CPT Pharmacometrics Syst Pharmacol
; 2: e27, 2013 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23835938
6.
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels.
Eur J Clin Pharmacol
; 64(8): 775-81, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18458892
7.
Caring for people with developmental disabilities: survey of nurses about their education and experience.
Ment Retard
; 38(1): 33-41, 2000 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10703216
8.
Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal.
Phytomedicine
; 3(3): 281-5, 1996 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23195084
Resultados
1 -
8
de 8
1
Próxima >
>>